Pfizer has reportedly matched Novo Nordisk’s (NVO) offer to buy weight-loss drug start-up Metsera (MTSR) for up to $10 ...

Shares of Vigonvita Life Sciences surged in its Hong Kong debut, adding to the wave of Chinese healthcare and biopharmaceutical firms tapping the city's financial markets. The Suzhou-based company's ...

Chinese biotech firm Argo Biopharmaceutical Co. has picked banks for a Hong Kong initial public offering that could raise a ...

The immune drugmaker is the second biotech, along with MapLight Therapeutics, to recently use a workaround in U.S. securities ...

The wave of tech layoffs sweeping the Bay Area shows little sign of slowing, with new filings revealing job cuts at two major ...

Pfizer plans to sweeten its bid for Metsera , a person familiar with the matter told Reuters, after a judge denied its ...

According to a report from PEOPLE, Brady worked with biotech company Colossal Biosciences to clone his beloved dog Lua after ...

How much would you pay to never have to say goodbye to a beloved pet? If you've got enough cash, you might be able to.

The retired NFL quarterback worked with the biotech company known for its quest to bring back extinct species such as the ...

Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look ...

Former chemistry teacher Zhong Huijan’s Hansoh Pharmaceutical Group strikes potentially lucrative licensing deals with big ...

Amid the rapidly unfolding saga revolving around Metsera, a judge has denied Pfizer’s request to block Novo Nordisk’s buyout ...